Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick F Lang

Showing results (101-110 of 251) with videos related to

Pageof 26
Sort By:
Neurosurgery|May 1, 2009
Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patientsStefan S Kim, Ian E McCutcheon, Dima Suki, et al.
Neurosurgical Focus|August 1, 2025
Introduction. Surgical management of infiltrative gliomasFrederick F Lang, Jeffrey S Weinberg, Chibawanye I Ene, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Glycoconjugate Journal|June 27, 2009
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecanHuan He, Carol L Nilsson, Mark R Emmett, et al.
Neuro-Oncology Practice|August 7, 2019
Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy eraDhiego Chaves de Almeida Bastos, Marcos Vinicius Calfat Maldaun, Raymond Sawaya, et al.
Neuro-Oncology|August 16, 2024
The emerging field of viroimmunotherapy for pediatric brain tumorsMarc Garcia-Moure, Virginia Laspidea, Sumit Gupta, et al.
Journal of Neurosurgical Anesthesiology|September 23, 2016
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma PatientsMarkus M Luedi, Sanjay K Singh, Jennifer C Mosley, et al.
Neuro-Oncology Advances|January 12, 2024
MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapyVincent W S Leong, Sabbir Khan, Pratibha Sharma, et al.
Journal of Proteome Research|July 18, 2015
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell XenograftsNorelle C Wildburger, Shiyue Zhou, Lauren G Zacharias, et al.
Journal of Neurosurgery|September 7, 2019
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cellsVisish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Pageof 26

Showing results (101-110 of 251) with videos related to

Sort By:
Pageof 26
Neurosurgery|May 1, 2009
Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patientsStefan S Kim, Ian E McCutcheon, Dima Suki, et al.
Neurosurgical Focus|August 1, 2025
Introduction. Surgical management of infiltrative gliomasFrederick F Lang, Jeffrey S Weinberg, Chibawanye I Ene, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Glycoconjugate Journal|June 27, 2009
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecanHuan He, Carol L Nilsson, Mark R Emmett, et al.
Neuro-Oncology Practice|August 7, 2019
Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy eraDhiego Chaves de Almeida Bastos, Marcos Vinicius Calfat Maldaun, Raymond Sawaya, et al.
Neuro-Oncology|August 16, 2024
The emerging field of viroimmunotherapy for pediatric brain tumorsMarc Garcia-Moure, Virginia Laspidea, Sumit Gupta, et al.
Journal of Neurosurgical Anesthesiology|September 23, 2016
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma PatientsMarkus M Luedi, Sanjay K Singh, Jennifer C Mosley, et al.
Neuro-Oncology Advances|January 12, 2024
MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapyVincent W S Leong, Sabbir Khan, Pratibha Sharma, et al.
Journal of Proteome Research|July 18, 2015
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell XenograftsNorelle C Wildburger, Shiyue Zhou, Lauren G Zacharias, et al.
Journal of Neurosurgery|September 7, 2019
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cellsVisish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Pageof 26